Ghrelin enhances in vivo skeletal muscle but not liver AKT signaling in rats

Obesity

Volumn 15, Issue 11, 2007, Pages 2614-2623

  Barazzoni, Rocco ^a,b   Zanetti, Michela ^a   Cattin, Maria Rosa ^a   Visintin, Luca ^a   Vinci, Pierandrea ^a   Cattin, Luigi ^c   Stebel, Marco ^a   Guarnieri, Gianfranco ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c NONE

Author keywords

Adipokines; Ghrelin; Weight change

Indexed keywords

ADIPONECTIN; GHRELIN; GLUCOSE; GLUCOSE TRANSPORTER 4; GLYCOGEN SYNTHASE KINASE; LEPTIN; ONCOPROTEIN; RESISTIN; SLC2A4 PROTEIN, RAT; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BODY WEIGHT; DOSE RESPONSE; ENERGY METABOLISM; LIVER; MALE; METABOLISM; PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; WISTAR RAT;

ADIPONECTIN; ANIMALS; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENERGY METABOLISM; GHRELIN; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; GLYCOGEN SYNTHASE KINASES; LEPTIN; LIVER; MALE; MUSCLE, SKELETAL; ONCOGENE PROTEIN V-AKT; RATS; RATS, WISTAR; RESISTIN; SIGNAL TRANSDUCTION;

RATTUS;

EID: 38049055445     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2007.313     Document Type: Article

References (51)

1. Nakazato M, Murakami N, Date Y, et al. A role of ghrelin in the central regulation of feeding. Nature. 2001;409:194-198.
2. Wren AM, Small CJ, Abbott CR, et al. Ghrelin causes hyperphagia and obesity in rats. Diabetes. 2001;50:2540-7.
3. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000;407:908-13.
4. Thompson NM, Gill DA, Davies R, et al. Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology. 2004;145:234-42.
5. Broglio F, Gottero C, Benso A, et al. Effects of ghrelin on the insulin and glycemic responses to glucose, arginine, or free fatty acids load in humans. J Clin Endocrinol Metab. 2003; 88:4268-72.
6. Barazzoni R, Bosutti A, Stebel M, et al. Ghrelin regulates mitochondrial-lipid metabolism gene expression and fat distribution in liver and skeletal muscle Am J Physiol Endocrinol Metab. 2005;288:E228-35.
7. Murata M, Okimura Y, Iida K, et al. Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells. J Biol Chem. 2002;277:5667-74.
8. Gauna C, Delhanty PJD, Hofland LJ, et al. Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes. J Clin Endocrinol Metab. 2005;90: 1055-60.
9. Robertson MD, Henderson RA, Vist GE, Rumsey RD. Plasma ghrelin response following a period of acute overfeeding in normal weight men. Int J Obes Relat Metab Disord. 2004;28:727-33.
10. Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric by-pass surgery. N Engl J Med. 2002;346:1623-30.
11. Barazzoni R, Zanetti M, Stebel M, Biolo G, Cattin L, Guarnieri G. Hyperleptinemia prevents increased plasma ghrelin concentration during short-term moderate caloric restriction in rats. Gastroenterology. 2003;124:1188-92.
12. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes. 2001;50:707-9.
13. Shiiya T, Nakazato M, Mizuta M, et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab. 2002;87:240-4.
14. Purnell JQ, Weigle DS, Breen P, Cummings DE. Ghrelin levels correlate with insulin levels, insulin resistance, and high-density lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans. J Clin Endocrinol Metab. 2003;88:5747-52.
15. Poykko SM, Kellokoski E, Horkko S, Kauma H, Kesaniemi YA, Ukkola O. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes. 2003;52:2546-53.
16. McLaughlin T, Abbasi F, Lamendola C, Frayo RS, Cummings DE. Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls. J Clin Endocrinol Metab. 2004;89:1630-5.
17. Gauna C, Meyler FM, Janssen JAMJL, et al. Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity. J Clin Endocrinol Metab. 2004; 89:5035-42.
18. Heijboer AC, van den Hoek AM, et al. Ghrelin differentially affects hepatic and peripheral insulin sensitivity in mice Diabetologia. 2006;49:732-8.
19. Barazzoni R. Skeletal muscle mitochondrial protein metabolism and function in ageing and type 2 diabetes. Curr Opin Clin Nutr Metab Care. 2004;7:97-102.
20. Giovambattista A, Piermaria J, Suescun MO, Calandra RS, Gaillard RC, Spinedi E. Direct effect of ghrelin on leptin production by cultured rat white adipocytes. Obesity. 2006; 14:19-27.
21. Vendrell J, Broch M, Vilarrasa N, et al. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res. 2004;12:962-71.
22. Lee K, Villena JA, Moon YS, et al. Inhibition of adipogenesis and development of glucose intolerance by soluble preadipocyte factor-1 (Pref-1). J Clin Invest. 2003;111:453-61.
23. Kim KH, Zhao L, Moon Y, Kang C, Sul HS. Dominant inhibitory adipocyte-specific secretory factor (ADSF) resistin enhances adipogenesis and improves insulin sensitivity. Proc Natl Acad Ssi U S A. 2004;101:6780-5.
24. Kohn AD, Takeuchi F, Roth RA. Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation. J Biol Chem. 1996;271:21920-6.
25. Cross DAE, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 1995;378:785-9.
26. Holman GD, Kasuga M. From receptor to transporter: insulin signalling to glucose transport. Diabetologia. 1997;40:991-1003.
27. Puigserver P, Rhee J, Donovan J, et al. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature. 2003;423:550-5.
28. Daitoku H, Yamagata K, Matsuzaki H, Hatta M, Fukamizu A. Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR. Diabetes. 2003;52:642-9.
29. Southgate RJ, Bruce CR, Carey AL, et al. PGC-1alpha gene expression is down-regulated by Akt- mediated phosphorylation and nuclear exclusion of FoxO1 in insulin-stimulated skeletal muscle. FASEB J. 2005;19:2072-4.
30. Asmann YW, Stump CS, Short KR, et al. Skeletal muscle mitochondrial functions, mitochondrial DNA copy numbers, and gene transcript profiles in type 2 diabetic and nondiabetic subjects at equal levels of low or high insulin and euglycemia. Diabetes. 2006;55:3309-19.
31. Barazzoni R, Zanetti M, Bosutti A, et al. Moderate caloric restriction, but not physiological hyperleptinemia per se, enhances mitochondrial oxidative capacity in rat liver and skeletal muscle-tissue- specific impact on tissue triglyceride content and AKT activation. Endocrinology. 2005;146:2098-106.
32. Cheng JT, Huang CC, Liu IM, Tzeng TF, Chang CJ. Novel mechanism for plasma glucose-lowering action of metformin in streptozotocin-induced diabetic rats. Diabetes. 2006;55:819-25.
33. Short KR, Vittone JL, Bigelow ML, et al. Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes. 2003; 52:1888-96.
34. Baldanzi G, Filigheddu N, Cutrupi S, et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol. 2002;159:1029-37.
35. Samec S, Seydoux J, Dulloo AG. Interorgan signaling between adipose tissue metabolism and skeletal muscle uncoupling protein homologs: is there a role for circulating free fatty acids? Diabetes. 1998;47:1693-8.
36. Standaert ML, Sajan MP, Miura A, et al. Insulin-induced activation of atypical protein kinase C, but not protein kinase B, is maintained in diabetic (ob/ob and goto-kakazaki) liver: contrasting insulin signaling patterns in liver versus muscle define phenotypes of type 2 diabetic and high fat-induced insulin-resistant states. J Biol Chem. 2004;279:24929-34.
37. Escrivá F, Rodríguez C, Cacho J, Alvarez C, Portha B, Pascual-Leone AM. Glucose utilization and insulin action in adult rats submitted to prolonged food restriction. Am J Physiol Endocrinol Metab. 1992;263:E1-7.
38. Tritos NA, Kokkinos A, Lampadariou E, Alexiou E, Katsilambros N, Maratos-Flier E. Cerebrospinal fluid ghrelin is negatively associated with body mass index. J Clin Endocrinol Metab. 2003;88:2943-6.
39. Theander-Carrillo C, Wiedmer P, Cettour-Rose P, et al. Ghrelin action in the brain controls adipocyte metabolism. J Clin Invest. 2006;116:1983-93.
40. Filigheddu N, Gnocchi VF, Coscia M, et al. Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells. Mol Biol Cell. 2007;18:986-94.
41. Cassoni P, Ghe C, Marrocco T, Tarabra E, et al. Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines. Eur J Endocrinol. 2004;150:173-84.
42. Park SY, Cho YR, Kim HJ, et al. Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice. Diabetes. 2005;54: 3530-40.
43. Grimble RF. Fasting in healthy individuals and adaption to undernutrition during chronic disease. Curr Opin Clin Nutr Metab Care. 1998;1:369-74.
44. Hagopian K, Ramsey JJ, Weindruch R. Caloric restriction increases gluconeogenic and transaminase enzyme activities in mouse liver. Exp Gerontol. 2003;38:267-78.
45. Lee HM, Wang G, Englander EW, Kojima M, Greeley GH Jr. Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations. Endocrinology. 2002;143:185-90.
46. Reimer MK, Pacini G, Ahren B. Dose-dependent inhibition by ghrelin of insulin secretion in the mouse. Endocrinology. 2003;144:916-21.
47. Broglio F, Arvat E, Benso A, et al. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab. 2001;86:5083-6.
48. Damjanovic SS, Lalic NM, Pesko PM, et al. Acute effects of ghrelin on insulin secretion and glucose disposal rate in gastrectomized patients. J Clin Endocrinol Metab. 2006;91: 2574-81.
49. Murakami N, Hayashida T, Kuroiwa T, et al. Role for central ghrelin in food intake and secretion profile of stomach ghrelin in rats. J Endocrinol. 2002;174:283-8.
50. Tsubone T, Masaki T, Katsuragi I, et al. Leptin downregulates ghrelin levels in streptozotocin-induced diabetic mice. Am J Physiol Regul Integr Comp Physiol. 2005;289: R1703-6.
51. Rodriguez Ayala E, Pecoits-Filho R, Heimburger O, et al. Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study. Nephrol Dial Transplant. 2004;19:421-6.